How effective is vamorolone?

In a Phase I clinical trial in adult volunteers, vamorolone was shown to be safe and well-tolerated, and blood biomarker data suggest that corticosteroids may lose safety. In 48children with Duchennemuscular dystrophy(took medication for 2 weeks and stopped 2< In a Phase IIa dose-ranging clinical trial conducted this week, vamorolone was found to be safe and well-tolerated and showed blood biomarker data consistent with sarcolemma-stabilizing and anti-inflammatory effects, as well as possible loss of safety concerns. These children continued in an open-label extension study at the same dose for 24 weeks, which showed a dose-dependent improvement in motor outcomes, with 2.0 and 6.0 mg/kg/ days demonstrating benefit. These children continued in a dose-escalation long-term extension study, which demonstrated sustained clinical improvement through 18 months of treatment. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.